UPDATE 1-Bristol’s drug cocktail cuts kidney cancer death risk 37 pct

MADRID, Sept 10 (Reuters) – A combination of twoBristol-Myers Squibb immunotherapy drugs cut the risk ofdeath by 37 percent in a key group of kidney cancer patients,data from a closely watched clinical trial showed on Sunday.
The post UPDATE 1-Bristol’s drug cocktail cuts kidney cancer death risk 37 pct appeared first on RocketNews | Top News Stories From Around the Globe.